Coventry Group Limited Reports FY25 Sales Down 1.7%, EBITDA Plummets 40.9%

Reuters
08/05
Coventry Group Limited Reports FY25 Sales Down 1.7%, EBITDA Plummets 40.9%

Coventry Group Limited (ASX: CYG) announced its FY25 trading results, reporting a decrease in group sales to $365.2 million, down 1.7% compared to the prior year. The unaudited EBITDA for the same period was $12.3 million, reflecting a significant decline of 40.9% from the previous year. This downturn was attributed to softer market conditions across Australia and New Zealand, the challenges associated with the implementation of a new ERP system, and underperformance in sales growth strategies. Despite these challenges, the company maintained strong gross margins; however, the high cost base led to poor net margin outcomes. In the Fluid Systems segment, sales declined by 7.4%, contributing to the overall decrease in consolidated group sales. Additionally, the segment faced a one-off, pre-tax loss of approximately $1.3 million due to an onerous contract identified during the period. Looking ahead, Coventry Group Limited has set an earnings guidance for FY26 with an expected EBITDA exceeding $20 million. The group is focused on a "back to basics" strategy, emphasizing sales growth, cost reduction, cash generation, debt reduction, and a significant improvement in financial performance. The Board is confident in the market opportunities and believes the team is well-positioned to execute these strategic goals. July sales were reported at $34 million, marking a 6.3% increase from June, indicating an improving run-rate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coventry Group Limited published the original content used to generate this news brief on August 05, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10